Table 2 Patients outcomes
LTGN (n = 21) | LATLSN (n = 32) | P value | |
|---|---|---|---|
Mortality, n | 2 | 3 | 1.00 |
Postoperative morbidity, n | 6a | 17b | 0.04 |
Hemorrhage | 2 | 3 | |
Pancreatic fistula | 0 | 12 | |
Intra-abdominal infection | 3 | 3 | |
Enterocutaneous fistula | 1 | 1 | |
Clavien–Dindo ≥ III complications, n | 4 | 4 | 0.70 |
Additional percutaneous drainage, n | 2 | 2 | 1.00 |
Additional surgery, n | 3 | 5 | 1.00 |
ICU stay (days) | 6 (2–32) | 5 (1–21) | 0.76 |
Postoperative hospital stay (days) | 13 (6–43) | 11 (6–38) | 0.45 |
Recurrent WON, n | 2 | 2 | 1.00 |
Repeated surgery, n | 1 | 1 | 1.00 |
Long-term complications, n | 5 | 10 | 0.56 |
New-onset diabetes | 3 | 3 | |
Pancreatic exocrine insufficiency | 2 | 3 | |
Incisional hernia | 0 | 0 |